ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
9.25
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $37 million as of March 5, 2026. Its market cap has decreased by -38.08% in one year.
Market Cap
37.00M
Enterprise Value
37.76M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$9.25
Market Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 37.00M, an increase of 1,433.18%. That is a compound annual growth rate of 12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 37.00M | 7.96% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 70.56M |
| Nuo Therapeutics | 67.60M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |
| Arch Biopartners | 39.60M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Finch Therapeutics Group | 21.28M |
| Inhibitor Therapeutics | 21.21M |